Anavex Life Sciences (AVXL)
JonesTrading analyst Soumit Roy reiterated a Buy rating on Anavex Life Sciences today and set a price target of $40.00. The company’s shares closed last Tuesday at $7.69, close to its 52-week low of $7.29.
According to TipRanks.com, Roy is a 3-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Anavex Life Sciences with a $41.00 average price target.
Biohaven Pharmaceutical Holding Co (BHVN)
H.C. Wainwright analyst Douglas Tsao downgraded Biohaven Pharmaceutical Holding Co to Hold today and set a price target of $148.50. The company’s shares closed last Tuesday at $140.00, close to its 52-week high of $151.51.
According to TipRanks.com, Tsao is a 2-star analyst with an average return of
Biohaven Pharmaceutical Holding Co has an analyst consensus of Moderate Buy, with a price target consensus of $153.70, implying a 9.8% upside from current levels. In a report released today, SVB Securities also downgraded the stock to Hold with a $150.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on AVXL: